Schering-Plough Loses Suit Over Laxative Marketing

Law360, New York (March 4, 2008, 12:00 AM EST) -- A dispute among five drug companies about the marketing of a type of laxative as “prescription only” has resulted in a setback for Schering-Plough Healthcare Products Inc., with a judge denying the company's motion for summary judgment and agreeing to dismiss the case.

The case involves MiraLax, an over-the-counter oral laxative marketed by Schering-Plough. The company had sued four companies that produce a generic, prescription version of the same drug, polyethylene glycol 3350.

Schering-Plough alleged that in marketing their product as “prescription only,” the defendants were...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.